| Date | Title | Description |
| 04.11.2024 | Lipum will present at the BioStock Life Science Summit, November 21 | Lipum will present at the BioStock Life Science Summit, November 21
Mon, Nov 04, 2024 11:00 CET Report this content
The seventh edition of the BioStock Life Science Summit will take place in Lund on November 20-21. CEO Ola Sandborgh will pr... |
| 05.07.2024 | BioStock: Lipum strengthens the board with commercial expertise | BioStock: Lipum strengthens the board with commercial expertise
Fri, Jul 05, 2024 09:30 CET Report this content
Lipum has chosen to strengthen the Board of Directors with Åsa Magnusson, who has more than 30 years of experience in the pharma... |
| 20.06.2024 | BioStock: Lipum’s CEO comments on multiple-dose results in phase I | BioStock: Lipum’s CEO comments on multiple-dose results in phase I
Thu, Jun 20, 2024 08:45 CET Report this content
Following the positive single-dose results from the phase I study evaluating SOL-116, Lipum is now presenting additional prom... |
| 03.04.2024 | BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment | BioStock: Lipum seeks patent protecting inflammation-driven cancer treatment
Wed, Apr 03, 2024 10:49 CET Report this content
Lipum has submitted an international patent application for SOL-116 as a treatment for inflammation-driven cancer. ... |
| 22.03.2024 | BioStock: Lipum has included first RA patient | BioStock: Lipum has included first RA patient
Fri, Mar 22, 2024 10:56 CET Report this content
Lipum recently announced that the first patient with rheumatoid arthritis has been included and dosed in ongoing phase I clinical trial with SOL-1... |
| 29.05.2023 | Find your next investment at the BioStock Life Science Spring Summit on May 30 and 31! | Find your next investment at the BioStock Life Science Spring Summit on May 30 and 31!
Mon, May 29, 2023 09:45 CET Report this content
It is finally time for BioStock Life Science Spring Summit 2023! Around 30 companies from a wide range of... |
| 09.08.2022 | Lipum to participate in upcoming industry meetings | Lipum to participate in upcoming industry meetings
Tue, Aug 09, 2022 08:45 CET Report this content
News: Umeå, 9 August 2022. Lipum (publ), a biopharmaceutical company focused on chronic inflammatory diseases, today announced its participat... |
| 27.07.2022 | Lipum AB - interim report for the period January - June 2021 | Lipum AB - interim report for the period January - June 2021
Wed, Jul 27, 2022 08:00 CET Report this content
Press release: Umeå, 27 July, 2022. Lipum AB has published the interim report for period January to June 2022. Below is a short sum... |
| 08.07.2022 | Lipum has recruited Helena Bergström as Chief Medical Officer | Lipum has recruited Helena Bergström as Chief Medical Officer
Fri, Jul 08, 2022 08:30 CET Report this content
News: Umeå, 8 July, 2022. Lipum (publ) is preparing for the start of its first in human phase 1 clinical trial and the team is now... |
| 17.06.2022 | Lipum’s toxicology- and safety program of SOL-116 successfully completed | Lipum’s toxicology- and safety program of SOL-116 successfully completed
Fri, Jun 17, 2022 08:50 CET Report this content
Press release: Umeå, 17 June 2022. Lipum (publ) reports that the GLP toxicology- and safety program on the candidate dr... |
| 25.05.2022 | Lipum participates at Redeye Growth Day 2022 | Lipum participates at Redeye Growth Day 2022
Wed, May 25, 2022 11:30 CET Report this content
News: Umeå, 25 May 2022. In June, Lipum will present at Redeye Growth Day, EULAR 2022, Biostock Life Science Summit Spring and Aktiespararnas Småbo... |
| 18.05.2022 | Lipum AB – interim report for the period January-March 2022 | Lipum AB – interim report for the period January-March 2022
Wed, May 18, 2022 08:30 CET Report this content
Press release: Umeå, 18 May 2022. Lipum AB (publ) has published the interim report for period January to March for 2022. Below is a ... |
| 13.05.2022 | Lipum initiates collaboration with Pelago Bioscience | Lipum initiates collaboration with Pelago Bioscience
Fri, May 13, 2022 13:15 CET Report this content
News: Umeå, 13 May 2022. Lipum AB (publ) has started a collaboration with Pelago Bioscience AB to strengthen the bioanalytical development ... |
| 05.05.2022 | Lipum in consortium being granted research funding by KKS | Lipum in consortium being granted research funding by KKS
Thu, May 05, 2022 17:10 CET Report this content
Press release: Umeå, 5 May 2022. Lipum AB (publ) is one of the partners contributing to the KKS-Synergy grant application “Drug discov... |
| 07.04.2022 | Lipum abstract accepted for EULAR 2022 | Lipum abstract accepted for EULAR 2022
Thu, Apr 07, 2022 09:00 CET Report this content
News: Umeå, 7 April 2022. Lipum (publ) reports that the abstract entitled “A Novel Target for Treatment of Inflammatory Joint Diseases” has been selected... |
| 25.03.2022 | Lipum AB – Year-end report 2021 | Lipum AB – Year-end report 2021
Fri, Mar 25, 2022 06:00 CET Report this content
Press release: Umeå, 25 March 2022. Lipum AB (publ) has published the interim report for period October to December and the year-end report for 2021. Below is a... |
| 09.03.2022 | Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116 | Lipum has entered a partnership with QPS Netherlands B.V. for its first clinical trial with SOL-116
Wed, Mar 09, 2022 08:30 CET Report this content
Press release: Umeå, March 9, 2022. Lipum AB (publ) announce that the company has entered in... |
| 24.02.2022 | Lipum’s GMP production of SOL-116 successful | Lipum’s GMP production of SOL-116 successful
Thu, Feb 24, 2022 08:45 CET Report this content
Press release: Umeå, February 24, 2022. Lipum AB (publ) reports that the GMP manufacturing of SOL-116 has been successful and the drug product is n... |
| 02.02.2022 | Lipum recruits scientist | Lipum recruits scientist
Wed, Feb 02, 2022 13:00 CET Report this content
News: Umeå, 2 February, 2022. Lipum (publ) recruits Dr. Fredrik Seijsing to strengthen the preclinical development of SOL-116.
Lipum's development work is in an intens... |
| 22.12.2021 | Lipum AB - report from extra general meeting | Lipum AB - report from extra general meeting Wed, Dec 22, 2021 13:00 CET
Press release: Umeå, 22 December 2021. Extra general meeting in Lipum AB (publ), corporate identity number 556813-5999 (the “Company”) was held on 22 December 2021 in ... |
| 26.11.2021 | Lipum AB - interim report for the period July – September 2021 | Lipum AB - interim report for the period July – September 2021 Fri, Nov 26, 2021 08:30 CET
Press release: Umeå, 26 November 2021. Lipum AB (publ) has published the interim report for period July to September 2021. Below is a brief summary, ... |
| 26.11.2021 | Lipum AB - interim report for the period July - September 2021 | Press release: Umeå, 26 November 2021. Lipum AB (publ) has published the interim report for period July to September 2021. Below is a brief summary, a complete report (only in Swedish) is available on the company's website.
CEO
Einar Pontén... |
| 22.11.2021 | Lipum announces the Nomination Committee and that Flerie Invest AB has become a major shareholder | Lipum announces the Nomination Committee and that Flerie Invest AB has become a major shareholder Mon, Nov 22, 2021 08:30 CET
Press release: Umeå, November 22, 2021. Lipum AB (publ) (“Lipum”) announces that Flerie Invest AB has acquired all... |
| 01.11.2021 | Lipum has recruited Maria Wanderoy as Project Director for the Drug Development Program of SOL-116 | Lipum has recruited Maria Wanderoy as Project Director for the Drug Development Program of SOL-116 Mon, Nov 01, 2021 08:30 CET
Press release: Umeå, November 1, 2021. Lipum (publ) is proceeding towards start of clinical trials according to p... |
| 23.09.2021 | Lipum participate at the Naventus Life Science Summit | Lipum participate at the Naventus Life Science Summit Thu, Sep 23, 2021 08:30 CET
News: Umeå, 23 September 2021.
Lipum will participate at the Naventus Life Science Summit, 29 September at Grand Hôtel in Stockholm. The event is organized by... |
| 15.09.2021 | Lipum initiates GMP-production for clinical trials | Lipum initiates GMP-production for clinical trials Wed, Sep 15, 2021 08:30 CET
Press release: Umeå, September 15, 2021. Production of Lipum's drug candidate SOL-116 for use in clinical trials has according to plan been initiated by the comp... |
| 03.09.2021 | Lipum’s toxicology- and safety studies on the candidate drug SOL-116 progress according to plan | Lipum’s toxicology- and safety studies on the candidate drug SOL-116 progress according to plan Fri, Sep 03, 2021 08:30 CET
Press release: Umeå, September 3, 2021. The dose-finding toxicology- and safety studies on Lipum’s candidate drug (S... |
| 27.08.2021 | Lipum AB - interim report for the period January - June 2021 | Lipum AB - interim report for the period January - June 2021 Fri, Aug 27, 2021 08:30 CET
Press release: Umeå, 27 August, 2021. Lipum AB has published the interim report for period January to June 2021. Below is a brief summary, a complete r... |
| 25.08.2021 | Lipum participate at the LSX Nordic Congress | Lipum participate at the LSX Nordic Congress Wed, Aug 25, 2021 11:30 CET
News: Umeå, 25 august, 2021.
Lipums CEO Einar Pontén will present Lipum at LSX Nordic Virtual Congress 6-17 September. The LSX Nordic Congress is annual investment and... |
| 19.08.2021 | Professor Olle Hernell has received the Macy György award | Professor Olle Hernell has received the Macy György award Thu, Aug 19, 2021 11:30 CET
Press release: Umeå, 19 August, 2021. Professor Olle Hernell that is co-founder and board member of Lipum has been honored with the Macy György award 2021... |
| 24.05.2021 | The Life Science Spring Summit virtual event | The Life Science Spring Summit virtual event Mon, May 24, 2021 14:00 CET
News: Umeå, 24 May 2021.
On May 26 at 12:00 am Lipum will tell what´s going on in the company and what the future plans look like. Link to the event.
Welcome to meet u... |
